SEARCH

SEARCH BY CITATION

References

  • 1
    NIH. Helicobacter pylori in peptic ulcer disease. NIH Consensus Statement 1994; 12(1): 123.
  • 2
    European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41(1): 813.
  • 3
    Lam SK & Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13(1): 112.
  • 4
    Schultze V, Hackelsberger A, Gunther T, Miehlke S, Roessner A, Malfertheiner P. Differing patterns of Helicobacter pylori gastritis in patients with duodenal, prepyloric, and gastric ulcer disease. Scand J Gastroenterol 1998; 33(2): 13742.
  • 5
    Laszewicz W, Zaremba WA, Gabryelewicz A. Helicobacter pylori infection and gastric secretion in duodenal and gastric ulcer patients—the effect of eradication after one year. J Physiol Pharmacol 1997; 48(3): 35364.
  • 6
    Feldman M & Richardson CT. Total 24-hour gastric acid secretion in patients with duodenal ulcer. Comparison with normal subjects and effects of cimetidine and parietal cell vagotomy. Gastroenterology 1986; 90(3): 5404.
  • 7
    Derodra JK, Howden CW, Burget DW, Hunt RH. Twenty-four-hour intragastric acidity and nocturnal gastric secretion in gastric ulcer patients 0151 the effects of cimetidine. Aliment Pharmacol Ther 1990; 4(3): 27581.
  • 8
    Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 1996; 17(1): 112.
  • 9
    Chalmers TC, Smith HJ, Blackburn B, et al. A method for assessing the quality of a randomized controlled trial. Controlled Clin Trials 1981; 2(1): 3149.
  • 10
    Cho MK & Bero LA. Instruments for assessing the quality of drug studies published in the medical literature. J Am Med Assoc 1994; 272(2): 1014.
  • 11
    Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Controlled Clin Trials 1995; 16(1): 6273.
  • 12
    Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993; 2(2): 12145.
  • 13
    Petitti DB. Meta-analysis and endocrinology. Endocrinol Metab Clin North Am 1997; 26(1): 3144.
  • 14
    Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbe KA. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol 1992; 45(3): 25565.
  • 15
    Labenz J, Stolte M, Blum AL, et al. Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin. Gut 1995; 37(1): 3943.
  • 16
    Chu KM, Choi HK, Tuen HH, Law SY, Branicki FJ, Wong J. A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori. Am J Gastroenterol 1998; 93(9): 143642.
    Direct Link:
  • 17
    Habu Y, Mizuno S, Hirano S, et al. Triple therapy with omeprazole, amoxicillin and clarithromycin is effective against Helicobacter pylori infection in gastric ulcer patients as well as in duodenal ulcer patients. Results of a randomized controlled trial in Japan. Digestion 1998; 59(4): 3215.
  • 18
    Ellenrieder V, Fensterer H, Waurick M, Adler G, Glasbrenner B. Influence of clarithromycin dosage on pantoprazole combined triple therapy for eradication of Helicobacter pylori. Aliment Pharmacol Ther 1998; 12(7): 6138.DOI: 10.1046/j.1365-2036.1998.00354.x
  • 19
    Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997; 315(7109): 62934.
  • 20
    Axon AT, O'Morain CA, Bardhan KD, et al. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection. Br Med J 1997; 314(7080): 5658.
  • 21
    Lazzaroni M, Perego M, Bargiggia S, et al. Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study. Ital J Gastroenterol Hepatol 1997; 29(3): 2207.
  • 22
    Seppala K, Pikkarainen P, Sipponen P, Kivilaakso E, Gormsen MH. Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Finnish Gastric Ulcer Study Group. Gut 1995; 36(6): 8347.
  • 23
    Bayerdorffer E, Miehlke S, Mannes GA, et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995; 108(5): 14127.
  • 24
    Bianchi Porro G, Lazzaroni M, Bargiggia S, et al. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence. Am J Gastroenterol 1996; 91(4): 695700.
  • 25
    Bell GD, Bate CM, Axon AT, et al. Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole. Aliment Pharmacol Ther 1996; 10(4): 63744.
  • 26
    Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328(5): 30812.
  • 27
    Logan RP, Bardhan KD, Celestin LR, et al. Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomized, double-blind, multi-centre trial of omeprazole with or without clarithromycin. Aliment Pharmacol Ther 1995; 9(4): 41723.
  • 28
    Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110(4): 124452.
  • 29
    Santander C, Gravalos RG, Gomez CA, Cantero J, Pajares JM. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. Am J Gastroenterol 1996; 91(8): 154952.
  • 30
    Kato M, Asaka M, Kudo M, et al. Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients. Aliment Pharmacol Ther 1996; 10(5): 8217.
  • 31
    Yang HB, Sheu BS, Su IJ, Chien CH, Lin XZ. Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication. Dig Dis Sci 1997; 42(9): 183540.
  • 32
    Glaser J, Hein J, Daikeler R, et al. Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection. Med Klin 1998; 93(2): 659.
  • 33
    Bertoni G, Sassatelli R, Nigrisoli E, et al. Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. Am J Gastroenterol 1996; 91(2): 25863.
  • 34
    Riemann JF, Schilling D, Schauwecker P, et al. Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding. Gastrointest Endosc 1997; 46(4): 299304.
  • 35
    Bianchi PG, Parente F, Imbesi V, Montrone F, Caruso I. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in long-term NSAID users. Response to omeprazole dual therapy. Gut 1996; 39(1): 226.
  • 36
    Miehlke S, Mannes GA, Lehn N, Hele C, Stolte M, Bayerdorffer E. An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively. Aliment Pharmacol Ther 1997; 11(2): 3239.
  • 37
    Labenz J, Idstrom JP, Tillenburg B, Peitz U, Adamek RJ, Borsch G. One-week low-dose triple therapy for Helicobacter pylori is sufficient for relief from symptoms and healing of duodenal ulcers. Aliment Pharmacol Ther 1997; 11(1): 8993.
  • 38
    Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 1990; 99(2): 34551.
  • 39
    Howden C, Burget DW, Hunt R. A meta-analysis to predict gastric ulcer healing from acid suppression. Gastroenterology 1991; 100: A85A85(Abstract).
  • 40
    Hunt RH, Cederberg C, Dent J, et al. Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci 1995; 40(Suppl. 2): 24S49S.
  • 41
    Malfertheiner P & Labenz J. Does Helicobacter pylori status affect nonsteroidal anti-inflammatory drug-associated gastroduodenal pathology? Am J Med 1998; 104(3A): 35S40S.
  • 42
    Asaka M, Ohtaki T, Kato M, et al. Causal role of Helicobacter pylori in peptic ulcer relapse. J Gastroenterol 1994; 29(Suppl. 7): 1348.
  • 43
    Chan FK, Sung JJ, Lee YT, et al. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori? Am J Gastroenterol 1997; 92(3): 4425.
  • 44
    Dalla LM, Pazzi P, Carli G, et al. High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication. Aliment Pharmacol Ther 1996; 10(2): 2036.
    Direct Link:
  • 45
    Fujioka T, Uribe RU, Kubota T, Murakami K, Kawasaki H, Nasu M. Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study. Eur J Gastroenterol Hepatol 1995; 7(Suppl. 1): S358.
  • 46
    Furuta T, Futami H, Arai H, Hanai H, Kaneko E. Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori. J Clin Gastroenterol 1995; 20(Suppl. 2): S10711.
  • 47
    Gabryelewicz A, Laszewicz W, Dzieniszewski J, et al. Multicenter evaluation of dual-therapy (omeprazole and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation). J Physiol Pharmacol 1997; 48(Suppl. 4): 93105.
  • 48
    Labenz J, Gyenes E, Ruhl GH, Borsch G. Two weeks treatment with amoxicillin/omeprazole for eradication of Helicobacter pylori. Z Gastroenterol 1992; 30(11): 7768.
  • 49
    Labenz J & Borsch G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994; 89(10): 17858.
  • 50
    Labenz J & Borsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994; 55(1): 1923.
  • 51
    Moreno JA, Pajares JM, Santander C, et al. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients. J Gastroenterol 1996; 31(Suppl. 9): 4852.
  • 52
    Pilotto A, Franceschi M, Di Mario F, Leandro G, Bozzola L, Valerio G. The long-term clinical outcome of elderly patients with Helicobacter pylori-associated peptic ulcer disease. Gerontology 1998; 44(3): 1538.
  • 53
    Suzuki J, Mine T, Kobayasi I, Fujita T. Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan. Helicobacter 1998; 3(1): 5963.
  • 54
    Uemura N, Okamoto S, Mukai T, et al. Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin. Eur J Gastroenterol Hepatol 1995; 7(Suppl. 1): S679.
  • 55
    Van-der-Hulst R, Rauws EA, Koycu B, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 1997; 113(4): 10826.